A Custom Pharmacogenetic Test is a tailored genetic analysis designed to evaluate specific genes involved in drug metabolism and response, based on a patient’s medical history and current medications. This personalized approach enables healthcare providers to predict how a patient will respond to specific drugs, leading to more accurate and effective treatment plans.

4-5 weeks

PCR / Sanger Sequencing / NGS

EDTA Blood, DNA

Pharmacogenomics is particularly valuable in psychiatric care, where genetic variations can influence how patients respond to medications used to treat mental health conditions. The Genomind Test helps identify patients who are more likely to benefit from certain psychiatric medications or who are at risk for adverse drug reactions, enabling more precise treatment and dosage optimization.

14 business days

qPCR

Sample collection kit provided by BION

The DPYD Test identifies patients with dihydropyrimidine dehydrogenase (DPD) deficiency, a genetic condition that affects the body’s ability to metabolize fluoropyrimidine chemotherapy drugs, such as 5-fluorouracil (5-FU) and capecitabine. Knowing a patient’s DPD status can help tailor cancer treatments to avoid severe toxic reactions.

4-6 business days

PCR

Peripheral Blood, DNA